YD Bio (YDES) Financial Statements & Analysis

YD Bio (YDES) Income Statement

YD Bio reported revenue of $596.82K in fiscal 2025 (fiscal year ended Dec 31, 2025), up 16.9% from $510.36K a year earlier. YD Bio posted a net loss of $8.31M, compared with a net loss of $1.41M a year earlier. Gross margin was 28.1% and operating margin -882.7%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $423.25K.

YD Bio Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

YD Bio Limited income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.60	0.51	0.35	0.36	0.00	0.00
Cost of Revenue	0.43	0.36	0.20	0.23	0.00	0.00
Gross Profit	0.17	0.16	0.15	0.13	0.00	0.00
Operating Expenses
Research & Development	1.60	0.49	0.00	0.00	0.00	0.00
Selling, General & Administrative	3.82	1.13	0.16	0.18	1.72	0.34
Operating Expenses	5.44	1.62	0.16	0.18	1.72	0.34
Operating Income	-5.27	-1.46	-0.01	-0.05	-1.72	-0.34
Other Income/Expense
Interest Income	0.08	0.01	0.00	0.00	0.00	0.00
Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	-3.12	0.08	0.03	0.00	10.43	-2.19
Income
Income Before Tax	-8.31	-1.39	0.02	-0.05	8.70	-2.54
Income Tax Expense	0.00	0.03	0.00	0.00	0.00	0.00
Net Income	-8.31	-1.41	0.01	-0.05	8.70	-2.54
Net Income - Continuous Operations	-8.31	-1.41	0.01	3.79	8.70	-2.54
Net Income - Discontinued Operations	-	-	-	-	-	-
EBITDA	-8.10	-1.36	0.02	-0.04	8.70	-2.54
EBIT	-8.31	-1.46	-0.01	-0.04	-	-
Depreciation & Amortization	0.02	0.10	0.00	0.00	0.00	0.00
Earnings Per Share
Basic EPS	-	-	-	-	1.00	-
Diluted EPS	-	-1.00	-	-	1.00	-
Basic Shares Outstanding	66.72	64.73	70.10	1.05	14.63	14.63
Diluted Shares Outstanding	66.72	64.73	70.10	1.05	14.63	14.63

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About YD Bio Financial Statements

What was YD Bio's revenue in fiscal 2025?

YD Bio reported revenue of $596.82K in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 16.9% from $510.36K a year earlier.

Is YD Bio profitable?

No. YD Bio reported a net loss of $8.31M in fiscal 2025. In fiscal 2024 it lost $1.41M.

What is YD Bio's operating margin?

YD Bio's operating income was −$5.27M on revenue of $596.82K in fiscal 2025, an operating margin of -882.7%, compared with -286.5% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition